Share
9,106 Posts.
lightbulb Created with Sketch. 7857
clock Created with Sketch. 31/10/23
11:46
Share
Originally posted by truss20:
↑
"The GvHD is a strategical error in my opinion, but nothing I say going to change that. The largest partnered Phase III Knee OA trial of its kind will dictate this company's future"
Expand
Truss I despised the old MSB vs CYP arguments and my posting history will show often tried to diffuse, but before I commented, all we had on a rather important qtrly, was two old MSB foes of Sector disparaging, such is the lack of interest or discussion on CYP (they need not worry), an Australian company soon to complete recruitment in the biggest global IPSC trial to date globally, unless I am misinformed. That is a crying shame for Australian scientific research more generally.
Last edited by
bedger :
31/10/23
(20min delay)